BMS-986490
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 02, 2026
CA238-0001: A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=360 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting
Enrollment closed • First-in-human • Gastric Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
February 16, 2025
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=360 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open • Gastric Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
December 12, 2024
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=360 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
Metastases • New P1/2 trial • Gastric Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1